Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder voting results from TPG RE Finance Trust's 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing reports voting outcomes for three proposals: election of eight directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on executive compensation. The detailed vote tallies (For, Against, Withheld, Abstentions, and Broker Non-Votes) for each proposal are the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-21
Item 2.02
The filing discloses Copart's financial results for the third quarter of fiscal year 2026 (ended April 30, 2026) via a press release issued on May 21, 2026 and furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02, which would materially affect a reasonable investor's assessment of the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 1.01
GATX Corporation amended its Five Year Credit Agreement on May 21, 2026, extending the termination date by one year to May 21, 2031 and reducing borrowing margins and facility fees. This material refinancing/restructuring of existing debt terms does not constitute an acquisition, disposition, or change of control.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 1.01
Victory Capital entered into a Seventh Amendment to its Credit Agreement on May 18, 2026, refinancing existing term loans with repriced term loans at lower interest rates (SOFR plus 1.75% or alternate base rate plus 0.75%), materially affecting the company's debt structure and cost of capital.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
Alphabet closed a ¥576.9 billion (~$3.8 billion USD equivalent) underwritten public offering of Japanese yen-denominated senior notes across seven tranches with maturities from 2029 to 2066. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the standard M&A, dilutive equity issuance, or other specific event categories—it is a debt financing activity disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
ClearPoint Neuro held its Annual Meeting of stockholders and disclosed voting results for four proposals: election of seven directors, ratification of Cherry Bekaert LLP as auditors, advisory approval of executive compensation, and approval of the Seventh Amended and Restated 2013 Incentive Compensation Plan. All proposals were approved by shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-21
Item 5.07
Third Coast Bancshares held its Annual Meeting of Shareholders on May 21, 2026, with voting results on three matters: election of directors to Classes A and C, approval of the Restated Omnibus Incentive Plan (increasing share reserves by 375,000 shares and modifying equity award terms), and ratification of Whitley Penn LLP as independent auditor.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-05-21
Item 5.02
While the section discloses both an executive departure (William R. Devlin retiring as Chief Accounting Officer effective June 1, 2026) and an appointment (Samuel M. Guzman Jr. becoming Senior Vice President, Chief Accounting Officer and Controller), the bulk of the Item 5.02 disclosure centers on Item 5.02(e) compensatory arrangements. The Compensation Committee approved three incentive compensation programs (Eagle Plan, Business Unit Plan, and Special Situation Program) with specific bonus pools, performance metrics, and maximum bonus potentials for named executive officers. The compensation disclosure is more extensive and material than the succession narrative, making exec_compensation the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
Amit Muni was appointed as Executive Vice President and Chief Financial Officer effective June 8, 2026, succeeding Michael Donohue. The appointment includes compensatory terms including a base salary of $450,000, guaranteed bonuses, and RSU awards.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-21
Item 3.01
Hub Group received a notice from Nasdaq on May 19, 2026 that it failed to comply with Listing Rule 5250(c)(1) by not timely filing its Q1 2026 Form 10-Q. The company has been granted until June 3, 2026 to submit a compliance plan and until September 14, 2026 to file delinquent reports, with potential delisting if compliance is not regained within the prescribed timeframe.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Charles Schwab issued $2.25 billion in aggregate principal amount of senior notes ($1 billion at 4.744% due 2030 and $1.25 billion at 5.493% due 2037) with net proceeds of approximately $2.236 million. This is a material debt issuance that does not fit the dilutive_issuance category (which applies to equity securities) and is not a covenant breach, restatement, or other more specific event type. The disclosure of a substantial debt offering is material to investors assessing the registrant's capital structure and financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-05-21
Item 1.01
Onto Innovation issued $1.7 billion in aggregate principal amount of 0.00% Convertible Senior Notes due 2031, convertible into common stock at an initial conversion price of approximately $381.80 per share, with net proceeds of approximately $205 million used to repurchase 805,325 shares. The convertible notes represent a significant dilutive capital raise with substantial equity component and conversion potential affecting shareholder equity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-21
Item 1.01
Kraft Heinz issued €1 billion in aggregate principal amount of senior notes on May 21, 2026, pursuant to a shelf registration statement, with proceeds earmarked for a concurrent tender offer to repurchase outstanding senior notes due 2046 and 2049. This debt refinancing activity—combining new issuance with debt repurchase—constitutes a material capital structure transaction affecting the company's financial position and leverage profile.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from Bruker Corporation's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports final vote tallies for three proposals: election of Class II directors (Laura A. Francis, John J. Phillips, Hermann F. Requardt), advisory approval of 2025 named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. This is a quintessential Item 5.07 disclosure of shareholder voting outcomes, which is material to investors as it reflects governance decisions and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Verisk Analytics' 2026 Annual Meeting held on May 19, 2026. The filing presents detailed voting tallies for four proposals: election of eleven board directors, say-on-pay advisory vote, auditor ratification, and a shareholder proposal on written consent rights. The comprehensive vote counts and named director nominees are unmistakable indicators of shareholder meeting results.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 2.03
EagleRock Land assumed a $263.3 million Predecessor Credit Facility (maturing July 3, 2027) and entered into a new $200 million revolving Credit Facility with JPMorgan Chase in connection with its IPO closing, materially altering the company's capital structure and leverage position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This Item 5.07 disclosure reports the results of Willis Towers Watson's 2026 Annual General Meeting held on May 20, 2026, including voting outcomes on director elections, auditor ratification, executive compensation approval, share issuance authorities, and employee share plan amendments. The filing presents detailed vote tallies for each proposal, which is the core content of shareholder vote results disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
Choice Hotels held its Annual Meeting of Shareholders on May 21, 2026, with shareholders voting on four proposals: election of eleven directors, advisory vote on executive compensation, amendment to the Certificate of Incorporation to expand the Board size range from 3-12 to 5-15 directors, and ratification of Ernst & Young LLP as independent auditor. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-21
Item 8.01
LSB Industries announced on May 18, 2026 that it will assume full ownership of a carbon capture and sequestration project from Lapis Carbon Solutions, with total consideration and remaining capital estimated at approximately $95 million. This constitutes a material acquisition or change of control of the Project, meeting the threshold for ma_activity disclosure under Item 8.01 (Other Events), with contingent consideration tied to milestone achievement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This Item 5.07 filing discloses the final voting results from LSB Industries' 2026 annual meeting of stockholders held on May 21, 2026. The section presents detailed vote tallies for three matters: election of three director nominees (Jonathan Z. Ackerman, Diana M. Peninger, and Lynn F. White), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, and the directors were duly elected to serve until 2029.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
FMC announced the pricing of a $1.2 billion offering of Senior Secured Notes due 2031. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial position, it does not fit cleanly into the taxonomy's more specific categories (ma_activity applies to acquisitions/dispositions/mergers, not debt offerings; dilutive_issuance applies to equity securities). The disclosure is material but best classified as other_material given the debt financing nature.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-05-21
Item 3.02
Hims & Hers issued $402.5 million in convertible notes on May 21, 2026, to qualified institutional buyers under Rule 144A, with up to 18,057,397 shares of Class A common stock potentially issuable upon conversion at an initial conversion price of $29.53 per share. This private placement of convertible securities represents a material dilutive issuance that will result in equity dilution to existing shareholders upon conversion.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-05-21
Item 8.01
Olema Pharmaceuticals announced preliminary Phase 1 clinical data for OP-3136, a KAT6 inhibitor, demonstrating favorable safety, tolerability, and early efficacy signals including tumor shrinkage in 13 of 19 patients and 3 partial responses with no dose-limiting toxicities. This clinical progress is material to investors' assessment of the company's pipeline and development prospects.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-21
Item 8.01
The Company disclosed receipt of a Nasdaq notice on March 17, 2026 that it had failed to maintain the minimum market value of listed securities ($50 million) required under Nasdaq Listing Rule 5450(b)(2)(A). Although the Company subsequently regained compliance by May 20, 2026 based on stockholders' equity meeting Rule 5450(b)(1)(A), the disclosure centers on a delisting risk event—the failure to satisfy a continued listing rule and the subsequent resolution. This is material to investors as it directly affects the Company's ability to remain listed on Nasdaq.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
Item 1.01
Relay Therapeutics entered into an Underwriting Agreement on May 20, 2026, for an underwritten public offering of 22,916,667 shares at $12.00 per share, with underwriters exercising a full 30-day option for an additional 3,437,500 shares, generating approximately $296.8 million in net proceeds. This is a material registered equity issuance that dilutes existing shareholders and materially affects the company's capital structure and investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 45%
filed 2026-05-21
Item 8.01
This disclosure announces an upcoming stockholder vote on the conversion of Series B Preferred Stock that would trigger a change of control under Nasdaq rules (>20% dilution and control change per Rules 5635(a) and 5635(b)). However, the filing is pre-meeting notice rather than post-meeting results. The material substance is the announced change-of-control transaction requiring shareholder approval, which more closely aligns with ma_activity (change of control), though the Item 8.01 placement and focus on the voting mechanics creates ambiguity about the intended classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure announces an option agreement with Hangzhou DAC Biotechnology providing access to a linker-payload (CPT113) for up to five additional ADC programs, which expands the Company's pipeline. While this represents a material strategic development for a biotech company's product pipeline, it does not fit cleanly into the more specific event categories (not an M&A transaction, not an earnings release, not an executive change, and not a financial impairment or covenant breach). The pipeline expansion through a licensing/option agreement is material to investors assessing the company's future prospects but is best classified as other_material.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-21
Item 8.01
This Item 8.01 disclosure centers on supplemental disclosures related to a previously announced merger agreement between FONAR Corporation and entities controlled by CEO Timothy Damadian. The filing updates the Definitive Proxy Statement and Schedule 13E-3/A filed on April 16, 2026, in connection with a special stockholder meeting scheduled for May 28, 2026, to vote on the proposed merger. While the Item is technically "Other Events," the substance is material M&A activity—specifically, supplemental disclosures addressing stockholder litigation allegations regarding disclosure deficiencies in the merger proxy materials. The company voluntarily supplemented disclosures to avoid litigation risks and allow stockholders to vote on the merger.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-21
Item 1.01
Veritone entered into an at-the-market (ATM) equity offering agreement with three sales agents authorizing the sale of up to $50 million in common stock shares. This is a registered dilutive issuance under Rule 415(a)(4) that would materially affect existing shareholders through potential equity dilution and is a significant capital-raising activity for the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
The filing discloses the appointment of Michael Weinbach as CEO-Elect effective June 1, 2026, and subsequently as Chief Executive Officer and Board member effective August 13, 2026, succeeding retiring CEO Richard G. Thornberry. While the section also covers compensatory arrangements (base salary of $1,000,000, STI target of $1,166,666, and LTI awards totaling $6,000,000 plus sign-on equity), the principal disclosed action is Weinbach's appointment to the CEO role and the Board, making this an executive appointment event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
Kohl's Corporation held its Annual Meeting of Shareholders on May 20, 2026, with voting results on four proposals: election of eight directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as independent auditor, and approval of the amended 2024 Long-Term Compensation Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-05-21
Item 5.07
Shareholders voted on and approved amendments to the Company's Certificate of Formation and Bylaws, including removal of references to SoftBank and a terminated Governance Agreement, and addition of an election under Texas Business Organizations Code Section 21.419.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses that unit holders may elect to separately trade Class A ordinary shares and warrants commencing May 21, 2026, with separated securities trading under distinct NYSE symbols (KPET and KPET.WS). This is a structural change affecting the trading and composition of the company's securities, which would materially affect investor options and the total mix of information available. However, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or other defined event type), warranting classification as other_material.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-21
Item 1.01
Crown PropTech Acquisitions entered into Amendment No. 2 to its business combination agreement with Mkango Rare Earths Limited, modifying key transaction terms including the Exchange Ratio, share issuances, intercompany debt settlement conditions, and Registration Rights and Lock-Up Agreement provisions. The company also filed a Form F-4 registration statement relating to the proposed business combination, a material SPAC merger transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-05-21
Item 1.01
Amanat Acquisition Corp. consummated its IPO on May 18, 2026, raising $75 million in gross proceeds from the sale of 7.5 million Class A shares at $10 per share, and entered into multiple ancillary agreements including underwriting, trust, registration rights, and indemnification agreements governing the offering and post-IPO operations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
Item 3.02
The Sponsor purchased 300,000 Class A Ordinary Shares in a private placement at $10.00 per share for $3,000,000 in gross proceeds, subject to transfer restrictions and redemption waivers, demonstrating sponsor alignment in the newly public company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
Three independent directors—Rakhi Kumar, Brad Middlekauff, and Patrick Crutcher—were appointed to the board in connection with the IPO on May 18, 2026, and concurrently appointed to key board committees including Audit, Compensation, and Nominating and Corporate Governance.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-21
Item 5.03
The Company's articles of incorporation were amended and filed with the Cayman Islands General Registry on May 18, 2026 in connection with the IPO, with substantive terms incorporated by reference to the Registration Statement, though the specific governance changes are not detailed in the 8-K excerpt.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-21
The filing discloses entry into an Agreement and Plan of Merger on May 20, 2026, whereby Neo North Star Resources, Inc. will merge into Greenland Rare Earths Corp., a wholly owned subsidiary of Greenland Mines Ltd. The consideration totals $35 million ($20 million cash and $15 million in newly issued common stock), representing a material acquisition transaction. This is a classic Item 1.01 disclosure of entry into a material agreement constituting M&A activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-21
The filing discloses the completion of a material acquisition of Omnisys Ltd. for an aggregate purchase price of $196.6 million in Ondas Inc. common stock, with 100% of Omnisys's issued and outstanding shares acquired pursuant to a Share Purchase Agreement dated May 16, 2026. Item 2.01 explicitly states "Completion of Acquisition or Disposition of Assets," and the transaction is clearly material to investors given its substantial size and the significant equity consideration involved.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-21
The filing discloses the appointment of Zhong Li as an independent director effective May 18, 2026, with assignment to the Audit, Compensation, and Nominating and Corporate Governance Committees. While the filing also mentions the concurrent resignation of Ningrong Liu, the substantive disclosure centers on the appointment of a new director with detailed background information highlighting his 20+ years of experience in finance, regulation, and technology across multiple jurisdictions and institutions. For a SPAC, director appointments are material governance events affecting investor assessment of board composition and oversight capability.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-21
Item 5.02
Christian Nolet resigned from the Board of Directors effective May 15, 2026. While the filing also mentions the appointment of Svetlana Lucas to the Audit Committee, the principal disclosed action is Nolet's departure from the Board. Board departures are material to investors as they affect governance and oversight. The explicit statement that the resignation is not due to disagreement mitigates some concern but does not eliminate materiality.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Blackstone Secured Lending Fund disclosed the issuance and closing of $650 million in aggregate principal amount of 5.900% notes due 2031 on May 21, 2026, pursuant to an Eleventh Supplemental Indenture. While this is a material debt issuance that would affect a reasonable investor's assessment of the Fund's capital structure and financial obligations, it does not fit neatly into the more specific event categories (e.g., it is not a restatement, covenant breach, or going-concern disclosure). The disclosure focuses on the terms, covenants, and mechanics of the debt offering rather than a discrete triggering event like a breach or impairment.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure announces board approval of an increase and extension of the Company's stock repurchase program. While share repurchase programs can signal management confidence in valuation and affect capital allocation, this announcement does not fit cleanly into the more specific event categories (it is not an earnings release, executive change, M&A activity, impairment, or other defined material event). The materiality to investors lies in the capital allocation decision and potential impact on share count and EPS, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-21
Item 1.01
Trinity Capital entered into an underwriting agreement on May 19, 2026, for the issuance and sale of $300 million in 7.000% Notes due 2031, which closed on May 21, 2026, with net proceeds of approximately $294.54 million. The proceeds are earmarked for repayment of existing secured indebtedness, representing a material refinancing activity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-21
Item 1.01
Hoth Therapeutics entered into two exclusive license agreements with Virginia Commonwealth University on May 15, 2026, granting its subsidiary Rocket One exclusive and non-exclusive rights to patents and technical information in the data center and AI field, with royalty payments, minimum annual payments, and sublicensing rights.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
Hoth Therapeutics announced a material name change to Rocket One, Inc. and a fundamental strategic pivot from therapeutics to artificial intelligence infrastructure, semiconductors, and ultra-low-power AI computing.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This disclosure describes the completion of a SPAC IPO and related capital-raising activities, including the initial IPO of 16 million units generating $160 million in gross proceeds, private placement of 5.2 million warrants, and subsequent exercise of the underwriter's over-allotment option for 1.5 million additional units generating $15 million. While the IPO itself is a material capital event, it does not fit cleanly into the "earnings_release" category (which typically applies to periodic financial results) or "dilutive_issuance" (which focuses on unregistered equity sales to raise cash in distressed contexts). The disclosure is primarily a post-closing announcement of a completed IPO and related warrant issuances, which is material to investors but lacks a more specific event-type match.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 8.01
The disclosure announces that the Company's 11% Series B Cumulative Convertible Preferred Stock commenced trading on Nasdaq Global Market under symbol "FBYDP" on May 21, 2026. While this represents a significant capital structure event and public market listing of a security class, it does not fit cleanly into the standard taxonomy categories (not a dilutive issuance of common equity, not M&A activity, not a routine administrative matter). The event is material to investors as it affects the Company's capital structure and introduces a new publicly-traded security class.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-05-21
Item 8.01
The filing discloses that VenHub Global has regained compliance with Nasdaq Listing Rule 5450(a)(1) after the closing bid price of its Common Stock remained at $1.00 or greater for 10 consecutive business days. This directly addresses a delisting risk — the company was previously non-compliant with the minimum bid price rule and has now cured that deficiency. The materiality is high because delisting risk materially affects investor assessment of the registrant's continued market access and trading liquidity.
View raw filing on EDGAR →